The Effects of Smoking on the Diagnostic Characteristics of Metabolic Syndrome: A Review
暂无分享,去创建一个
[1] Shi Chen,et al. Relationship between the duration of smoking and blood pressure in Han and ethnic minority populations: a cross-sectional study in China , 2021, BMC Public Health.
[2] Ahmed Jamal,et al. Tobacco Product Use Among Adults — United States, 2019 , 2020, MMWR. Morbidity and mortality weekly report.
[3] Jason H. Y. Wu,et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis , 2020, BMJ.
[4] Katherine G. Hartley,et al. Association of smoking with abdominal adipose deposition and muscle composition in Coronary Artery Risk Development in Young Adults (CARDIA) participants at mid-life: A population-based cohort study , 2020, PLoS medicine.
[5] R. Wong,et al. Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. , 2020, JAMA.
[6] R. Casas,et al. The Effect of Alcohol on Cardiovascular Risk Factors: Is There New Information? , 2020, Nutrients.
[7] B. Stamford,et al. Cigarette Smoking: An Accessory to the Development of Insulin Resistance , 2019, American journal of lifestyle medicine.
[8] T. B. Cole. Smoking Cessation and Reduction of Cardiovascular Disease Risk. , 2019, JAMA.
[9] Byung Jin Kim,et al. Association between Secondhand Smoke Exposure and Hypertension in 106,268 Korean Self-Reported Never-Smokers Verified by Cotinine , 2019, Journal of clinical medicine.
[10] You-e Yan,et al. Age Differences in the Relationship between Secondhand Smoke Exposure and Risk of Metabolic Syndrome: A Meta-Analysis , 2019, International journal of environmental research and public health.
[11] Chang-Hoon Lee,et al. Association between secondhand smoke exposure and hypertension in never smokers: a cross-sectional survey using data from Korean National Health and Nutritional Examination Survey V, 2010–2012 , 2018, BMJ Open.
[12] N. Ohte,et al. Oxidative Stress is Closely Associated with Increased Arterial Stiffness, Especially in Aged Male Smokers without Previous Cardiovascular Events: A Cross-Sectional Study , 2017, Journal of atherosclerosis and thrombosis.
[13] Shen Gao,et al. Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease , 2017, Chronic diseases and translational medicine.
[14] T. Friedman,et al. Association between secondhand smoke and obesity and glucose abnormalities: data from the National Health and Nutrition Examination Survey (NHANES 1999–2010) , 2017, BMJ Open Diabetes Research and Care.
[15] W. Aronow. Association of obesity with hypertension. , 2017, Annals of translational medicine.
[16] E. Casiglia,et al. Effects of smoking on central blood pressure and pressure amplification in hypertension of the young , 2016, Vascular medicine.
[17] S. Prasad,et al. Synergistic protective effect of folic acid and vitamin B12 against nicotine-induced oxidative stress and apoptosis in pancreatic islets of the rat , 2016, Pharmaceutical biology.
[18] Blair H. Smith,et al. Effect of Smoking on Blood Pressure and Resting Heart RateCLINICAL PERSPECTIVE , 2015 .
[19] F. Hu,et al. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. , 2015, The lancet. Diabetes & endocrinology.
[20] Zhiwen Li,et al. Effects of passive smoking on hypertension in rural Chinese nonsmoking women , 2015, Journal of hypertension.
[21] M. Fluharty,et al. Correction. Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. , 2015, BMJ open.
[22] M. Matoulek,et al. No difference in hypertension prevalence in smokers, former smokers and non-smokers after adjusting for body mass index and age: a cross-sectional study from the Czech Republic, 2010 , 2015, Tobacco induced diseases.
[23] Blair H. Smith,et al. Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium , 2015, BMJ Open.
[24] Z. Keidar,et al. Smoking cessation-related weight gain--beneficial effects on muscle mass, strength and bone health. , 2015, Addiction.
[25] H. Middlekauff,et al. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. , 2014, Journal of the American College of Cardiology.
[26] V. Crippa,et al. Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome , 2014, Acta Diabetologica.
[27] Lihua Chen,et al. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia. , 2014, Journal of clinical lipidology.
[28] F. Galletti,et al. Not smoking is associated with lower risk of hypertension: results of the Olivetti Heart Study. , 2014, European journal of public health.
[29] S. Hilsenbeck,et al. Agonistic induction of PPARγ reverses cigarette smoke-induced emphysema. , 2014, The Journal of clinical investigation.
[30] G. Pacini,et al. Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite. , 2014, European journal of endocrinology.
[31] B. Lushniak,et al. The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .
[32] Z. Peng,et al. Effects of cigarette smoking on HDL quantity and function: Implications for atherosclerosis , 2013, Journal of cellular biochemistry.
[33] E. Feskens,et al. Associations between smoking, components of metabolic syndrome and lipoprotein particle size , 2013, BMC Medicine.
[34] H. Cena,et al. Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers , 2013, Diabetology & Metabolic Syndrome.
[35] R. Eckel,et al. Novel and Reversible Mechanisms of Smoking-Induced Insulin Resistance in Humans , 2012, Diabetes.
[36] G. Ning,et al. Active Smoking and Risk of Metabolic Syndrome: A Meta-Analysis of Prospective Studies , 2012, PloS one.
[37] S. Y. Lee,et al. Cigarette Smoking Increases Abdominal and Visceral Obesity but Not Overall Fatness: An Observational Study , 2012, PloS one.
[38] Z. Yan-ling,et al. Cigarette smoking and its association with serum lipid/lipoprotein among Chinese nonagenarians/centenarians , 2012, Lipids in Health and Disease.
[39] P. Aveyard,et al. Weight gain in smokers after quitting cigarettes: meta-analysis , 2012, BMJ : British Medical Journal.
[40] M. Czech,et al. What causes the insulin resistance underlying obesity? , 2012, Current opinion in endocrinology, diabetes, and obesity.
[41] Y. Balhara. Tobacco and metabolic syndrome , 2012, Indian journal of endocrinology and metabolism.
[42] H. Cena,et al. Relationship between smoking and metabolic syndrome. , 2011, Nutrition reviews.
[43] N. Benowitz,et al. Cigarette Smoking, Nicotine, and Body Weight , 2011, Clinical pharmacology and therapeutics.
[44] F. Paccaud,et al. Dose-dependent positive association between cigarette smoking, abdominal obesity and body fat: cross-sectional data from a population-based survey , 2011, BMC public health.
[45] Xiaoping Liu,et al. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. , 2011, American journal of physiology. Heart and circulatory physiology.
[46] Megan E. Piper,et al. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. , 2011, American heart journal.
[47] K. Asayama,et al. Association of environmental tobacco smoke exposure with elevated home blood pressure in Japanese women: the Ohasama study , 2010, Journal of hypertension.
[48] L Ghiadoni,et al. Cigarette smoking and hypertension. , 2010, Current pharmaceutical design.
[49] I. Siloși,et al. Tumor necrosis factor-α serum levels in healthy smokers and nonsmokers , 2010, International Journal of Chronic Obstructive Pulmonary Disease.
[50] Louise Pilote,et al. The effect of smoking on arterial stiffness , 2010, Hypertension Research.
[51] K. Kohara,et al. Smoking status is associated with serum high molecular adiponectin levels in community-dwelling Japanese men. , 2010, Journal of atherosclerosis and thrombosis.
[52] R. Touyz,et al. Oxidative Stress and Hypertension: Current Concepts , 2010, Current hypertension reports.
[53] C. A. Johnson,et al. Environmental tobacco use and indicators of metabolic syndrome in Chinese adults. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[54] B. Duncan,et al. Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus , 2010, Annals of Internal Medicine.
[55] S. Tanni,et al. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients , 2010, Journal of Inflammation.
[56] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[57] I. I. Skeva,et al. Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. , 2009, Atherosclerosis.
[58] R. Eckel,et al. Lipoprotein lipase : from gene to obesity , 2009 .
[59] Byung Jin Kim,et al. Association of Smoking Status, Weight Change, and Incident Metabolic Syndrome in Men: A 3-Year Follow-Up Study , 2009, Diabetes Care.
[60] T. Funahashi,et al. Smoking cessation is associated with increased plasma adiponectin levels in men. , 2009, Journal of cardiology.
[61] S. Jee,et al. Serum adiponectin is associated with smoking status in healthy Korean men. , 2009, Endocrine journal.
[62] H. Gerstein,et al. Maternal nicotine exposure increases oxidative stress in the offspring. , 2008, Free radical biology & medicine.
[63] H. Ueshima,et al. Relation of Blood Pressure and All-Cause Mortality in 180 000 Japanese Participants: Pooled Analysis of 13 Cohort Studies , 2008, Hypertension.
[64] Ming-Tsang Wu,et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. , 2008, Metabolism: clinical and experimental.
[65] F. Paccaud,et al. Consequences of smoking for body weight, body fat distribution, and insulin resistance. , 2008, The American journal of clinical nutrition.
[66] E. Levy,et al. Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[67] K. Nadeau,et al. Insulin Resistance: Childhood Precursors of Adult Disease , 2020, Definitions.
[68] Yutaka Oiso,et al. Smoking status and adiponectin in healthy Japanese men and women. , 2007, Preventive medicine.
[69] K. Hoffmann,et al. The effects of cigarette smoking on C-reactive protein concentrations in men and women and its modification by exogenous oral hormones in women , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[70] G. Can,et al. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefit. , 2007, Atherosclerosis.
[71] D. Bernhard,et al. Smoking, oxidative stress and cardiovascular diseases--do anti-oxidative therapies fail? , 2007, Current medicinal chemistry.
[72] M. Lee,et al. Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. , 2007, American journal of hypertension.
[73] T. Jørgensen,et al. Waist circumference and weight following smoking cessation in a general population: the Inter99 study. , 2007, Preventive medicine.
[74] A. Saiki,et al. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. , 2007, Diabetes research and clinical practice.
[75] C. Kirschbaum,et al. The relationship between smoking status and cortisol secretion. , 2007, Journal of Clinical Endocrinology and Metabolism.
[76] B. Isik,et al. Oxidative Stress in Smokers and Non-smokers , 2007, Inhalation toxicology.
[77] M. Urashima,et al. Risk of metabolic syndrome persists twenty years after the cessation of smoking. , 2007, Internal medicine.
[78] P. Whincup,et al. Modifiable Lifestyle Factors and the Metabolic Syndrome in Older Men: Effects of Lifestyle Changes , 2006 .
[79] Lyla M. Hernandez,et al. Genes, Behavior, and the Social Environment:: Moving Beyond the Nature/Nurture Debate , 2006 .
[80] J. Karbowska,et al. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[81] E. Kobayashi,et al. A longitudinal study of the influence of smoking on the onset of obesity at a telecommunications company in Japan. , 2006, Preventive medicine.
[82] P. Kenny,et al. Nicotine Self-Administration Acutely Activates Brain Reward Systems and Induces a Long-Lasting Increase in Reward Sensitivity , 2006, Neuropsychopharmacology.
[83] P. Guyenet. The sympathetic control of blood pressure , 2006, Nature Reviews Neuroscience.
[84] Carlos Iribarren,et al. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study , 2006, BMJ : British Medical Journal.
[85] P. Jurák,et al. Sympathetic neural responses to smoking are age dependent , 2006, Journal of hypertension.
[86] Richard W Morris,et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.
[87] Kanehisa Morimoto,et al. Association between lifestyle factors and plasma adiponectin levels in Japanese men , 2005, Lipids in Health and Disease.
[88] Y. Yoon,et al. Association between cigarette smoking and metabolic syndrome: the Korea National Health and Nutrition Examination Survey. , 2005, Diabetes care.
[89] T. Ogihara,et al. Association of Hypoadiponectinemia With Smoking Habit in Men , 2005, Hypertension.
[90] Kenji Suzuki,et al. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. , 2005, Industrial health.
[91] E. Hellström‐Lindahl,et al. Evidence for functional nicotinic receptors on pancreatic β cells , 2005 .
[92] D. Gordon,et al. High-Density Lipoprotein Cholesterol and Cardiovascular Disease , 2005 .
[93] L. Niskanen,et al. Inflammation, Abdominal Obesity, and Smoking as Predictors of Hypertension , 2004, Hypertension.
[94] S. Heymsfield,et al. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. , 2004, Metabolism: clinical and experimental.
[95] S. Wonnacott,et al. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. , 2004, Trends in pharmacological sciences.
[96] B. Stamford,et al. Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C. , 2004, Preventive medicine.
[97] P. Havel. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. , 2004, Diabetes.
[98] G. Berglund,et al. Changes in blood pressure and body weight following smoking cessation in women , 2004, Journal of internal medicine.
[99] W. Ricart,et al. Smoking, fat mass and activation of the tumor necrosis factor-α pathway , 2003, International Journal of Obesity.
[100] Harvey F Lodish,et al. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. , 2003, Cytokine & growth factor reviews.
[101] T. Fukui,et al. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. , 2003, Preventive medicine.
[102] W. Koenig,et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). , 2003, European heart journal.
[103] H. Struijker‐Boudier,et al. Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.
[104] S. Houterman,et al. Smoking, Blood Pressure and Serum Cholesterol—Effects on 20-Year Mortality , 2003, Epidemiology.
[105] T. Hirano,et al. Measurement of the serum lipoprotein lipase concentration is useful for studying triglyceride metabolism: Comparison with postheparin plasma. , 2003, Metabolism: clinical and experimental.
[106] D. Talmage,et al. Nicotinic receptor-mediated effects on appetite and food intake. , 2002, Journal of neurobiology.
[107] S. Beske,et al. Sympathetic Neural Activation in Visceral Obesity , 2002, Circulation.
[108] S. Jee,et al. Effect of smoking on the paradox of high waist-to-hip ratio and low body mass index. , 2002, Obesity research.
[109] W. White,et al. Impact of smoking cessation on ambulatory blood pressure and heart rate in postmenopausal women. , 2001, American journal of hypertension.
[110] B. Nicklas,et al. Weight gain and adipose tissue metabolism after smoking cessation in women , 2001, International Journal of Obesity.
[111] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[112] J. Després,et al. Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[113] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[114] D. Jacobs,et al. Effects of Smoking Cessation on Changes in Blood Pressure and Incidence of Hypertension: A 4-Year Follow-Up Study , 2001, Hypertension.
[115] A. Righetti,et al. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. , 2000, Circulation.
[116] M. Rewers,et al. Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. , 1999, Annals of epidemiology.
[117] A. Goldberg,et al. Effects of cigarette smoking and its cessation on body weight and plasma leptin levels. , 1999, Metabolism: clinical and experimental.
[118] A. Assali,et al. Weight gain and insulin resistance during nicotine replacement therapy , 1999, Clinical cardiology.
[119] W. Jaross,et al. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. , 1998, Respiration physiology.
[120] C. Packard,et al. The effect of smoking on post‐heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma , 1998, European journal of clinical investigation.
[121] M. Winniford,et al. Cigarette smoking increases sympathetic outflow in humans. , 1998, Circulation.
[122] M. Taskinen,et al. Smoking cessation improves insulin sensitivity in healthy middle‐aged men , 1997, European Journal of Clinical Investigation.
[123] S. Kjeldsen,et al. Predictors of 7‐year changes in exercise blood pressure: effects of smoking, physical fitness and pulmonary function , 1997, Journal of hypertension.
[124] M. Taskinen,et al. The insulin resistance syndrome and postprandial lipid intolerance in smokers. , 1997, Atherosclerosis.
[125] M. Laakso,et al. Smoking Is Independently Associated With High Plasma Insulin Levels in Nondiabetic Men , 1996, Diabetes Care.
[126] M. Taskinen,et al. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. , 1996, Circulation.
[127] J. Hokanson,et al. Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.
[128] P. Barnes,et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.
[129] A. Frati,et al. Acute Effect of Cigarette Smoking on Glucose Tolerance and Other Cardiovascular Risk Factors , 1996, Diabetes Care.
[130] G. Schillaci,et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension , 1995, Journal of hypertension.
[131] P. Arner,et al. Cholinoceptor‐mediated effects on glycerol output from human adipose tissue using in situ microdialysis , 1995, British journal of pharmacology.
[132] J. Morrow,et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.
[133] G. Mancia,et al. Mechanisms Responsible for Sympathetic Activation by Cigarette Smoking in Humans , 1994, Circulation.
[134] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[135] J. Manson,et al. The primary prevention of myocardial infarction. , 1992, The New England journal of medicine.
[136] G. Reaven,et al. Insulin resistance and cigarette smoking , 1992, The Lancet.
[137] R. Moffatt,et al. Cessation from cigarette smoking: changes in body weight, body composition, resting metabolism, and energy consumption. , 1991, Metabolism: clinical and experimental.
[138] T. Byers,et al. Smoking cessation and severity of weight gain in a national cohort. , 1991, The New England journal of medicine.
[139] E. Berry,et al. Smoking depresses adipose lipoprotein lipase response to oral glucose , 1990, European journal of clinical investigation.
[140] R. Jackson,et al. Relationship between Post-Heparin Plasma Lipases, Triglycerides and High Density Lipoproteins in Normal Subjects , 1990, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[141] E. Barrett-Connor,et al. Cigarette smoking and increased central adiposity. , 1989, Annals of internal medicine.
[142] J. Haddow,et al. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. , 1989, BMJ.
[143] R. Andres,et al. Studies in the distribution of body fat. III. Effects of cigarette smoking. , 1989, JAMA.
[144] D. Gordon,et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.
[145] N. Benowitz. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. , 1988, The New England journal of medicine.
[146] J. Palca. Nicotine addiction , 1988, Nature.
[147] D. Levy,et al. Cholesterol and mortality. 30 years of follow-up from the Framingham study. , 1987, JAMA.
[148] M. Kawakami,et al. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. , 1987, Journal of biochemistry.
[149] E Jucha,et al. Blood pressure in smokers and nonsmokers: epidemiologic findings. , 1986, American heart journal.
[150] R. Fell,et al. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. , 1986, The American journal of clinical nutrition.
[151] E. Jéquier,et al. Increased 24-hour energy expenditure in cigarette smokers. , 1986, The New England journal of medicine.
[152] R. Fell,et al. Cigarette smoking, exercise and high density lipoprotein cholesterol. , 1984, Atherosclerosis.
[153] R. Fell,et al. Cigarette smoking, physical activity, and alcohol consumption: relationship to blood lipids and lipoproteins in premenopausal females. , 1984, Metabolism: clinical and experimental.
[154] A. Goldberg,et al. Cigarettes smoking and adipose tissue lipoprotein lipase. , 1980, International journal of obesity.
[155] P. Cryer,et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. , 1976, The New England journal of medicine.
[156] J. Huttunen,et al. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. , 1976, Clinical science and molecular medicine.